Australian Civil Construction Entity, State Road Constructions, Selects Intelligent Fingerprinting Drug Screening System as Workplace Drug Screening Solution
27 nov. 2023 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
Intelligent Bio Solutions Inc. Reports Fiscal 2024 First Quarter Financial Results and Operational Highlights
08 nov. 2023 16h21 HE
|
Intelligent Bio Solutions, Inc.
- First fiscal quarter revenue and government support income increased 191% year-over-year and 88% sequentially due to strong organic growth and execution of expansion plans - - Increased market...
Intelligent Bio Solutions’ Innovative Drug Screening Technology Now Offered in New Zealand
24 oct. 2023 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
Intelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing Client
05 oct. 2023 08h30 HE
|
Intelligent Bio Solutions, Inc.
VKVP Haulage adopts Fingerprint Drug Screening System to help drive proactive drug testing policy Auctus Management Group successfully completes 25,000 tests using the Company’s Intelligent...
Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option
04 oct. 2023 16h05 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions,...
Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
02 oct. 2023 08h32 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions,...
Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business
27 sept. 2023 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
Intelligent Bio Solutions Successfully Debuts Intelligent Fingerprinting Drug Screening Solution at the 2023 Workplace Health & Safety Show in Sydney, Australia
21 sept. 2023 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test
08 sept. 2023 09h00 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Operational Highlights
24 août 2023 07h30 HE
|
Intelligent Bio Solutions, Inc.
- Combined full-year revenue and government support income increased 355% year-over-year - - Received guidance from U.S. FDA on a regulatory pathway for its Intelligent Fingerprinting Drug Screening...